
What is… Health Economics and Health Economic Evaluation
In the Wednesday morning session entitled Can’t or Won’t Pay: Health Economics and Bleeding Disorders, Jamie O’Hara describes the many
Year: 2021
Language: English
Author(s): World Federation of Hemophilia
Format: Video
In this session from the Global Policy and Access Summit, Dawn Rotellini, Mark Skinner, Jamie O’Hara and David Page will present an overview of the current state of access to therapies for people with bleeding disorders. Speakers will also highlight the importance of patient-relevant data on treatment choices and health policy decision-making. Session will include a case study and concrete recommendations will be brought forward for patient organizations to advocate for increased access to therapies.
The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.
The WFH does not promote any particular pharmaceutical product and any mention of any commercial brand in this presentation is strictly for educational purposes.

In the Wednesday morning session entitled Can’t or Won’t Pay: Health Economics and Bleeding Disorders, Jamie O’Hara describes the many

In the Tuesday afternon session on Health Technology Assessments (HTA), Mark Skinner introduces the topic and then Cliff Goodman and

Volunteer team members, and their beneficiaries, often have differing opinions on what projects should be of highest priority for an

A self-assessment is a useful exercise for organizations to take a closer look at what they do and how they

The strength of the WFH and of its national member organizations lies in the commitment of inspiring leaders who work

This guide explains how a national procurement system of factor concentrates can help to ensure that people with bleeding disorders